<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:53:50Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10510935" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10510935</identifier>
        <datestamp>2023-09-21</datestamp>
        <setSpec>bmjo</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMJ Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id>
              <journal-id journal-id-type="hwp">bmjopen</journal-id>
              <journal-id journal-id-type="publisher-id">bmjopen</journal-id>
              <journal-title-group>
                <journal-title>BMJ Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2044-6055</issn>
              <publisher>
                <publisher-name>BMJ Publishing Group</publisher-name>
                <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10510935</article-id>
              <article-id pub-id-type="pmcid">PMC10510935</article-id>
              <article-id pub-id-type="pmc-uid">10510935</article-id>
              <article-id pub-id-type="pmid">37723108</article-id>
              <article-id pub-id-type="pmid">37723108</article-id>
              <article-id pub-id-type="publisher-id">bmjopen-2023-075172</article-id>
              <article-id pub-id-type="doi">10.1136/bmjopen-2023-075172</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Methods</subject>
                </subj-group>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>1506</subject>
                  <subject>1730</subject>
                </subj-group>
                <series-title>Protocol</series-title>
              </article-categories>
              <title-group>
                <article-title>Patient randomised controlled trial of technology enabled strategies to promote treatment adherence in liver transplantation: rationale and design of the TEST trial</article-title>
              </title-group>
              <contrib-group>
                <contrib id="author-86277559" contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4899-2160</contrib-id>
                  <name>
                    <surname>Serper</surname>
                    <given-names>Marina</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-107423116" contrib-type="author">
                  <name>
                    <surname>Burdzy</surname>
                    <given-names>Alexander</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-94090436" contrib-type="author">
                  <name>
                    <surname>Schaubel</surname>
                    <given-names>Douglas E</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-107423118" contrib-type="author">
                  <name>
                    <surname>Mason</surname>
                    <given-names>Richard</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-107423119" contrib-type="author">
                  <name>
                    <surname>Banerjee</surname>
                    <given-names>Arpita</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-107423120" contrib-type="author">
                  <name>
                    <surname>Goldberg</surname>
                    <given-names>David S</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib id="author-109660170" contrib-type="author">
                  <name>
                    <surname>Martin</surname>
                    <given-names>Eric F</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib id="author-104780324" contrib-type="author">
                  <name>
                    <surname>Mehta</surname>
                    <given-names>Shivan J</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-96106361" contrib-type="author">
                  <name>
                    <surname>Russell</surname>
                    <given-names>Louise B</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib id="author-109660191" contrib-type="author">
                  <name>
                    <surname>Cheung</surname>
                    <given-names>Amanda C</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">6</xref>
                </contrib>
                <contrib id="author-97728646" contrib-type="author">
                  <name>
                    <surname>Ladner</surname>
                    <given-names>Daniela P</given-names>
                  </name>
                  <xref rid="aff7" ref-type="aff">7</xref>
                </contrib>
                <contrib id="author-79365573" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0549-1809</contrib-id>
                  <name>
                    <surname>Yoshino Benavente</surname>
                    <given-names>Julia</given-names>
                  </name>
                  <xref rid="aff8" ref-type="aff">8</xref>
                </contrib>
                <contrib id="author-28935649" contrib-type="author">
                  <name>
                    <surname>Wolf</surname>
                    <given-names>Michael S</given-names>
                  </name>
                  <xref rid="aff8" ref-type="aff">8</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>1</label><institution content-type="department">Division of Gastroenterology and Hepatology, Department of Medicine</institution>, <institution specific-use="Ringgold_14640">Perelman School of Medicine, University of Pennsylvania</institution>, <addr-line content-type="city">Philadelphia</addr-line>, <addr-line content-type="state">Pennsylvania</addr-line>, <country>USA</country></aff>
              <aff id="aff2"><label>2</label><institution content-type="department">Department of Biostatistics, Epidemiology and Informatics</institution>, <institution specific-use="Ringgold_14640">Perelman School of Medicine, University of Pennsylvania</institution>, <addr-line content-type="city">Philadelphia</addr-line>, <addr-line content-type="state">Pennsylvania</addr-line>, <country>USA</country></aff>
              <aff id="aff3"><label>3</label><institution content-type="department">Department of Psychiatry</institution>, <institution specific-use="Ringgold_14640">Perelman School of Medicine, University of Pennsylvania</institution>, <addr-line content-type="city">Philadelphia</addr-line>, <addr-line content-type="state">Pennsylvania</addr-line>, <country>USA</country></aff>
              <aff id="aff4"><label>4</label><institution content-type="department">Division of Digestive Health and Liver Diseases, Department of Medicine</institution>, <institution specific-use="Ringgold_12235">University of Miami Miller School of Medicine</institution>, <addr-line content-type="city">Miami</addr-line>, <addr-line content-type="state">Florida</addr-line>, <country>USA</country></aff>
              <aff id="aff5"><label>5</label><institution content-type="department">Department of Medical Ethics and Health Policy</institution>, <institution>Perelman School of Medicine, University of Pennsylvania</institution>, <addr-line content-type="city">Philadelphia</addr-line>, <addr-line content-type="state">Pennsylvania</addr-line>, <country>USA</country></aff>
              <aff id="aff6"><label>6</label><institution content-type="department">Division of Gastroenterology and Hepatology, Department of Medicine</institution>, <institution>Feinberg School of Medicine, Northwestern University</institution>, <addr-line content-type="city">Chicago</addr-line>, <addr-line content-type="state">Illinois</addr-line>, <country>USA</country></aff>
              <aff id="aff7"><label>7</label><institution content-type="department">Department of Surgery</institution>, <institution>Feinberg School of Medicine, Northwestern University</institution>, <addr-line content-type="city">Chicago</addr-line>, <addr-line content-type="state">Illinois</addr-line>, <country>USA</country></aff>
              <aff id="aff8"><label>8</label><institution content-type="department">Center for Applied Health Research on Aging</institution>, <institution>Feinberg School of Medicine, Northwestern University</institution>, <addr-line content-type="city">Chicago</addr-line>, <addr-line content-type="state">Illinois</addr-line>, <country>USA</country></aff>
              <author-notes>
                <corresp><label>Correspondence to</label> Dr Marina Serper; <email>marinas2@pennmedicine.upenn.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>18</day>
                <month>9</month>
                <year>2023</year>
              </pub-date>
              <volume>13</volume>
              <issue>9</issue>
              <elocation-id>e075172</elocation-id>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>4</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>25</day>
                  <month>8</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <ali:free_to_read/>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense" start_date="2023-09-17">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="bmjopen-2023-075172.pdf"/>
              <self-uri content-type="reviewers-comments-pdf" xlink:href="bmjopen-2023-075172.reviewer_comments.pdf"/>
              <self-uri content-type="draft-revisions-pdf" xlink:href="bmjopen-2023-075172.draft_revisions.pdf"/>
              <abstract>
                <sec>
                  <title>Background and aims</title>
                  <p>Liver transplantation is a life-saving procedure for end-stage liver disease. However, post-transplant medication regimens are complex and non-adherence is common. Post-transplant medication non-adherence is associated with graft rejection, which can have long-term adverse consequences. Transplant centres are equipped with clinical staff that monitor patients post-transplant; however, digital health tools and proactive immunosuppression adherence monitoring has potential to improve outcomes.</p>
                </sec>
                <sec>
                  <title>Methods and analysis</title>
                  <p>This is a patient-randomised prospective clinical trial at three transplant centres in the Northeast, Midwest and South to investigate the effects of a remotely administered adherence programme compared with usual care. The programme monitors potential non-adherence largely levering text message prompts and phenotypes the nature of the non-adhere as cognitive, psychological, medical, social or economic. Additional reminders for medications, clinical appointments and routine self-management support are incorporated to promote adherence to the entire medical regimen. The primary study outcome is medication adherence via 24-hour recall; secondary outcomes include additional medication adherence (ASK-12 self-reported scale, regimen knowledge scales, tacrolimus values), quality of life, functional health status and clinical outcomes (eg, days hospitalised). Study implementation, acceptability, feasibility, costs and potential cost-effectiveness will also be evaluated.</p>
                </sec>
                <sec>
                  <title>Ethics and dissemination</title>
                  <p>The University of Pennsylvania Review Board has approved the study as the single IRB of record (protocol # 849575, V.1.4). Results will be published in peer-reviewed journals and summaries will be provided to study funders.</p>
                </sec>
                <sec>
                  <title>Trial registration number</title>
                  <p><ext-link xlink:href="NCT05260268" ext-link-type="ClinicalTrials.gov">NCT05260268</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>Clinical Trial</kwd>
                <kwd>Hepatobiliary disease</kwd>
                <kwd>Public health</kwd>
                <kwd>TRANSPLANT SURGERY</kwd>
                <kwd>Transplant medicine</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group id="funding-1">
                  <funding-source>
                    <institution-wrap>
                      <institution>the National Institutes of Health (NIH), National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK)</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01DK131547</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>special-feature</meta-name>
                  <meta-value>unlocked</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <boxed-text id="BX1" position="float">
              <caption>
                <title>Strengths and limitations of this study</title>
              </caption>
              <list list-type="bullet">
                <list-item>
                  <p>This is a multi-centre trial conducted in English and Spanish that includes de-novo liver and liver/kidney transplant recipients.</p>
                </list-item>
                <list-item>
                  <p>We will assess efficacy as well as implementation outcomes and costs.</p>
                </list-item>
                <list-item>
                  <p>Limitations include that clinical trial participants may be more engaged than average.</p>
                </list-item>
                <list-item>
                  <p>Findings may not apply to settings that do not use electronic health records or to patients who do not own or use cellphones.</p>
                </list-item>
              </list>
            </boxed-text>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p>Liver transplant (LT), while providing a substantial survival benefit for decompensated liver disease, is a costly and limited resource.<xref rid="R1" ref-type="bibr">1–4</xref> With advances in surgical techniques and immunosuppression (IS), 5-year post-transplant survival exceeds 70%.<xref rid="R5" ref-type="bibr">5</xref> However, LT recipients (LTRs) manage complex IS regimens to maintain graft function. LTRs must navigate complex health systems, adhere to lifestyle changes, clinical monitoring and take multiple medications with potential side effects and frequent dosing changes,<xref rid="R6" ref-type="bibr">6 7</xref> all requiring robust health literacy and self-management skills. LTRs take on average 11 medications and 39% report a medication change within the past 30 days.<xref rid="R6" ref-type="bibr">6</xref> Additionally, 38% of LT candidates have inadequate health literacy,<xref rid="R8" ref-type="bibr">8</xref> and lower health literacy is associated with poor treatment knowledge and higher IS non-adherence.<xref rid="R6" ref-type="bibr">6 9</xref></p>
              <p>Post-transplant non-adherence ranges from 17% to 40%.<xref rid="R10" ref-type="bibr">10–15</xref> A study showed that non-adherence assessed via self-report (likely underestimated) increased steadily from 6 months to 3 years post-LT and was present in about one of five LTRs.<xref rid="R16" ref-type="bibr">16</xref> Up to 25% of late acute rejection episodes (&gt;6 months post-LT and likely due to behavioural factors) are suspected to be caused by poor adherence.<xref rid="R17" ref-type="bibr">17 18</xref> Compounding this issue is the fact that often more intensive medical management is needed post-LT as IS leads to worsening hypertension, diabetes and excessive weight gain.<xref rid="R19" ref-type="bibr">19–21</xref> LTRs must also engage in routine care with primary and specialty care, obtain follow-up testing, maintain up-to-date age-appropriate cancer screening and vaccinations.<xref rid="R22" ref-type="bibr">22–24</xref> This creates a clinical challenge requiring multifaceted solutions.<xref rid="R25" ref-type="bibr">25–27</xref></p>
              <p>We propose a multifaceted approach to enhance post-transplant adherence and care: the Technology-Enabled Strategies to promote Treatment adherence in Liver Transplant (TEST). Guided by our conceptual framework, we leverage widely available technology<xref rid="R28" ref-type="bibr">28–35</xref> (electronic health record (EHR), mobile devices) in a ‘low touch’ manner to support and track regimen use and activate appropriate transplant centre clinical staff when specific problems are identified. Here, we provide an overview of the TEST strategy and describe the methods and rationale for evaluating this approach in a randomised-controlled trial (RCT) funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods and analysis</title>
              <sec id="s2-1">
                <title>Study design and aims</title>
                <p>TEST is a two-arm, prospective, patient-randomised, controlled trial at three large, diverse transplant centres with a goal of evaluating the effectiveness and implementation of the TEST strategy (<xref rid="F1" ref-type="fig">figure 1</xref>). Specifically, our aims are to: (1) investigate the effectiveness of the TEST strategy to improve adherence to IS and non-IS medication regimens, functional health status and health outcomes compared with usual care (<italic toggle="yes">over the course of 18 months</italic>); (2) determine the fidelity of each component of the intervention over time and identify patient, care partner, clinician or transplant centre factors associated with optimal implementation; (3) assess the cost-effectiveness of TEST from a transplant centre perspective.</p>
                <fig position="float" id="F1">
                  <label>Figure 1</label>
                  <caption>
                    <p>Description of TEST intervention. LT, liver transplant; TEST, Technology-Enabled Strategies to promote Treatment adherence in Liver Transplant; W2H, Way to Health.</p>
                  </caption>
                  <graphic xlink:href="bmjopen-2023-075172f01" position="float"/>
                </fig>
              </sec>
              <sec id="s2-2">
                <title>Patient and public involvement</title>
                <p>There was no patient or public involvement in the design of this study. However, study results will be disseminated to trial participants and the Liver Transplant Virtual Patient Support Group at the University of Pennsylvania.</p>
              </sec>
              <sec id="s2-3">
                <title>Setting</title>
                <p>The TEST trial is being conducted at the University of Pennsylvania, Northwestern University and the University of Miami from May 2022 to April 2027. The Penn Transplant Clinic (UPenn) is the largest multi-organ transplant centre in the Mid-Atlantic and ranks in the top 10 centres nationally with about 130–140 LTs annually. Northwestern Medicine Kovler Organ Transplant Center (Northwestern) is a large transplant centre in the Midwest that performs multi-organ transplantation and living donor LT (80–100 per year). The Miami Transplant Institute (Miami) is one of the largest transplant centres in the US based on transplant volumes with an average of 120–140 LTs performed annually.</p>
              </sec>
              <sec id="s2-4">
                <title>Usual care</title>
                <p>Usual care refers to the normal standard clinical practices immediately post-transplant to the 18 months following. All three sites have similar protocols for follow-up. LTRs have lab values taken weekly for the first 8–10 weeks post-transplant, shifting to every 2–4 weeks for the next 3–4 months, then monthly to every 3 months thereafter depending on clinical needs. All sites follow a similar schedule of tapering clinic visits ranging from weekly in the first 4 weeks to every 2–4 weeks in months 4–6, every 3–6 months in months 7–12 and every 6 months in months 12–24. All sites assign each patient to a specific transplant coordinator, first paired with a transplant surgeon (first 3–6 months), and then a transplant hepatologist for the remainder of follow-up. Visit windows of ±30 days have been built in to allow scheduling flexibility. All patients and care partners receive standard medication teaching prior to hospital discharge and then ad hoc. No routine text message reminders about adherence are used in usual care.</p>
              </sec>
              <sec id="s2-5">
                <title>Test intervention arm</title>
                <p>The TEST intervention is a technology-enabled strategy to routinely monitor regimen use, adherence and persistence via a ‘low touch’, easy to use, online behavioural toolkit—Way to Health (W2H). Patients randomised to the intervention will have the option to also have their care partners receive the alerts, study messages and monthly adherence assessments. The TEST strategy consists of several components designed to promote: (1) increased IS medication adherence, (2) routine surveillance of medication use and increased communication with transplant centre staff between clinic visits and (3) tailored clinical support based on individual challenges. The below components make up the TEST strategy:</p>
                <list list-type="bullet">
                  <list-item>
                    <p><italic toggle="yes">Two-tiered adherence assessments</italic> and <italic toggle="yes">clinician alerts</italic>: patients and care partners will separately receive monthly SMS text or online assessments of adherence barriers through W2H (<xref rid="F2" ref-type="fig">figure 2</xref>). We will deploy a two-tiered assessment to identify concerns among LTRs or care partners. The first tier will assess whether the patient is at risk for non-adherence (missed doses, missed timing, etc) and the second tier will phenotype the nature of their concern as cognitive (memory issues, limited health literacy), psychological (depression, health activation, alcohol/substance use), medical (health status, acute concerns), regimen (dosing complexity, side effects), social (unmet tangible support needs, transportation) and economic (costs). At UPenn the W2H portal is automatically integrated into the EHR; at Miami and Northwestern clinical research coordinators (RCs) will escalate the potential non-adherence alerts to the clinical team via email.</p>
                  </list-item>
                  <list-item>
                    <p><italic toggle="yes">Medication reminders</italic>: at enrolment, we will send the patient and designated care partner two times a day medication reminders via the W2H portal. Patients and care partners will have the opportunity to reassess their needs at baseline and every 6 weeks to customise the timing of these messages (two times a day, daily or opt out).</p>
                  </list-item>
                  <list-item>
                    <p><italic toggle="yes">Laboratory and appointment notifications</italic>: the W2H portal will send pre-programmed text message laboratory and appointment reminders starting within 3 months of enrolment to Miami and Northwestern, UPenn already uses automated text-based appointment reminders as part of usual care. The rationale for delaying messages is based on feedback from transplant clinicians who commented that patients receive a lot of communication from LT centres as part of usual care and that additional messages from the study may be burdensome.</p>
                  </list-item>
                  <list-item>
                    <p><italic toggle="yes">Supplemental self-management support</italic>: to maintain long-term health, LTRs must engage in routine appointments with primary or specialty care, receive follow-up imaging (eg, bone density scans, CT/MRI scans to monitor for liver cancer recurrence, age-appropriate cancer screening, vaccinations). We will leverage the W2H platform to schedule text message or email health reminders following evidence-based guidelines to help promote long-term post-transplant health. A Recovery Support Programme (RSP) will be available for LTRs with moderate to high-risk pretransplant alcohol use disorder, transplant for alcohol-associated hepatitis or risk of alcohol misuse post-transplant as determined by treating psychiatrist/hepatologist at each site. The RSP consists of 12 education videos on topics related to alcohol recovery and sustained abstinence. A questionnaire will be sent out at varying time points during the study to assess the risk of relapse. Care partners will have the option to be assigned questionnaires to help with monitoring.</p>
                  </list-item>
                </list>
                <fig position="float" id="F2">
                  <label>Figure 2</label>
                  <caption>
                    <p>Categories of two-tiered adherence assessment.</p>
                  </caption>
                  <graphic xlink:href="bmjopen-2023-075172f02" position="float"/>
                </fig>
              </sec>
              <sec id="s2-6">
                <title>Participants</title>
                <p>We plan to recruit 360 patients (n=120 per site) and up to 360 care partners at all sites over a 30-month period. Patients may enrol into the study without a care partner. Patient eligibility is as follows: (1) 18 years or older; (2) within 3 months of liver or liver/kidney transplant; (3) English-speaking or Spanish-speaking; (4) home-dwelling; (5) owns a smartphone and is comfortable receiving text messages and/or accessing the internet via smartphone. Care partner eligibility includes: (1) 18 years or older; (2) English-speaking or Spanish-speaking; (3) has access to a smartphone and is comfortable receiving text messages and/or accessing the internet via smartphone. Patients and/or care partners will be excluded if they have severe uncorrectable vision, hearing or cognitive impairments that may impede study interviews.</p>
              </sec>
              <sec id="s2-7">
                <title>Randomisation and blinding</title>
                <p>Block randomisation will occur within each site. Study patients will be allocated to either the TEST intervention group or usual care post-LT in a 1:1 ratio stratified by site with a block size of 2. At each site, approximately 120 LTRs will be randomised via the W2H platform at the beginning of the baseline visit. Patients randomised to the TEST intervention arm will have the option to have their care partner receive alerts and study messages as well as complete monthly adherence forms for them. The intervention will not be blinded to RCs, however, investigators will be blinded to group allocation.</p>
              </sec>
              <sec id="s2-8">
                <title>Human subjects protection and clinical trial registration</title>
                <p>The TEST trial is using a single Institutional Review Board (sIRB) to oversee the study at all sites with the University of Pennsylvania IRB serving as the IRB of record. RCs will obtain signed informed consent from all participants prior to their enrolment in the trial (see attached in <xref rid="SP1 SP2" ref-type="supplementary-material">online supplemental material</xref>).</p>
                <supplementary-material id="SP1" position="float" content-type="local-data">
                  <object-id pub-id-type="doi">10.1136/bmjopen-2023-075172.supp1</object-id>
                  <label>Supplementary data</label>
                  <p>
                    <inline-supplementary-material id="SS1" xlink:href="bmjopen-2023-075172supp001.pdf" content-type="local-data"/>
                  </p>
                </supplementary-material>
                <supplementary-material id="SP2" position="float" content-type="local-data">
                  <object-id pub-id-type="doi">10.1136/bmjopen-2023-075172.supp2</object-id>
                  <label>Supplementary data</label>
                  <p>
                    <inline-supplementary-material id="SS2" xlink:href="bmjopen-2023-075172supp002.pdf" content-type="local-data"/>
                  </p>
                </supplementary-material>
              </sec>
              <sec id="s2-9">
                <title>Recruitment and data collection</title>
                <p>Recruitment will begin with RCs prescreening potentially eligible patients in the EHR at each site. Eligibility will be confirmed with the local site PI.</p>
                <p>All potentially eligible participants and their care partners will be approached by the RC or site PI by telephone or in-person either prior to hospital discharge or during a post-transplant clinic visit. However, a patient can still enrol in the TEST trial without a care partner, and care partners may change throughout the study. A baseline study visit will take place after obtaining informed consent and within 90 days post-transplant. Follow-up study visits will be at 6, 12 and 18 months post-LT. Study data will be collected and managed using a REDCap (Research Electronic Data Capture) database hosted by the University of Pennsylvania Clinical Research Computing Unit, the data management team.</p>
              </sec>
              <sec id="s2-10">
                <title>Measurement</title>
                <sec id="s2-10-1">
                  <title>Patient covariates</title>
                  <p>Study measures and timing of assessments are shown in <xref rid="T1" ref-type="table">table 1</xref>. We will obtain sociodemographic information of both patients and care partners including but not limited to date of birth (DOB), age, address, sex assigned at birth, race, ethnicity and employment status. Lifetime occupational complexity will be used to measure premorbid cognitive function.<xref rid="R36" ref-type="bibr">36 37</xref> Preoperative and perioperative transplant health status will be measured by the Model for End-Stage Liver Disease (MELD) score at the time of LT,<xref rid="R38" ref-type="bibr">38</xref> liver disease aetiology, transplant hospitalisation length of stay,<xref rid="R39" ref-type="bibr">39</xref> discharge location<xref rid="R40" ref-type="bibr">40</xref> and medical comorbidities. Cognitive function will be measured with the Montreal Cognitive Assessment,<xref rid="R41" ref-type="bibr">41</xref> the Animal Naming Test<xref rid="R42" ref-type="bibr">42</xref> and visual acuity using the Rosenbaum Pocket Vision Screening Card using PV Numbers. We will use the Support with Medication Management Scale which assesses social support.<xref rid="R43" ref-type="bibr">43</xref> Healthcare navigation skills will be assessed using the ‘Liver Transplant Knowledge Questionnaire’ (LTKQ), a novel survey designed by our study team that tests knowledge regarding IS timing and side effects. We will assess health literacy with the Newest Vital Sign.<xref rid="R44" ref-type="bibr">44</xref></p>
                  <table-wrap position="float" id="T1">
                    <label>Table 1</label>
                    <caption>
                      <p>Study measures and timing of assessments</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <thead>
                        <tr>
                          <td align="left" valign="bottom" rowspan="2" colspan="1">Variable</td>
                          <td align="left" valign="bottom" rowspan="2" colspan="1">Instrument(s) or measure(s)</td>
                          <td align="left" valign="bottom" rowspan="1" colspan="4">Interview timepoint</td>
                        </tr>
                        <tr>
                          <td align="left" valign="bottom" rowspan="1" colspan="1">BL (day 0–90±30)</td>
                          <td align="char" char="." valign="bottom" rowspan="1" colspan="1">6 months (day 180±30)</td>
                          <td align="char" char="." valign="bottom" rowspan="1" colspan="1">12 months (day 360±30)</td>
                          <td align="char" char="." valign="bottom" rowspan="1" colspan="1">18 months (day 540±30)</td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Informed consent</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Informed consent</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="10" colspan="1">Sociodemographics</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Date of birth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Age</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Address</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Sex assigned at birth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Gender identity</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Race</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Ethnicity</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Marital status</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Employment</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Lifetime occupational complexity</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="5" colspan="1">Preoperative and perioperative transplant health status</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Model for End-Stage Liver Disease (MELD) score at time of LT</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Liver disease aetiology</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Transplant length of stay</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Discharge location</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Medical comorbidities</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="3" colspan="1">Cognitive status measurement</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Montreal Cognitive Assessment (MoCA)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Animal Naming Test (ANT)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Rosenbaum Visual Acuity</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Social support</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Modified Support with Medication Management Scale (SMMS)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Healthcare navigation skills</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Liver Transplant Knowledge Questionnaire (LTKQ)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Health literacy</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Newest Vital Sign (NVS)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="3" colspan="1">Medication adherence</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">24-Hour Recall, Regimen Knowledge</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Tacrolimus Lab Values</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">ASK-12</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="2" colspan="1">Health-related quality of life</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">EQ-5D-5L</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Alcohol, Tobacco and Drugs Survey</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="5" colspan="1">Functional health status</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Grip strength</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">30-second chair stand</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Balance test</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Liver Frailty Index calculation</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Most recent height, weight and BP</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="2" colspan="1">Chronic disease control</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Lipids (LDL, TG) and eGFR</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">HbA1c</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                      </tbody>
                    </table>
                    <table frame="hsides" rules="groups">
                      <thead>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="2">Care partner study measures and outcomes</td>
                          <td align="left" valign="top" rowspan="1" colspan="4">Interview timepoint</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Variable</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Instrument(s) or measure(s)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">BL (day 0–90±30)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">6 months (day 180±30)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">12 months (day 360±30)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">18 months (day 540±30)</td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Informed consent</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Informed consent</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="7" colspan="1">Sociodemographics</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Date of birth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Age</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Address</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Sex assigned at birth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Gender identity</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Race</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Ethnicity</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="3" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1">Marital status</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Employment</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Lifetime occupational complexity</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                          <td align="left" valign="top" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Self-efficacy</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Caregiver Inventory (CGI)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Preparedness</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Modified Caregiver Healthcare Task Difficulty and Preparedness Scale</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="4" colspan="1">Nature and intensity of care</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Relationship to patient</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Hours of care provided</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Duration of responsibility</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Nature of assistance provided</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Healthcare navigation skills</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Liver Transplant Knowledge Questionnaire (LTKQ)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Care partner burden</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Short Form Zarit Burden Interview (ZBI-12)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Physical and general health</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Physical and General Health Questionnaire</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">X</td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot>
                      <fn id="T1_FN1">
                        <p>eGFR, estimated glomerular filtration rate; LDL, low-density lipoprotein cholesterol; LT, liver transplant; TG, triglycerides.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
                <sec id="s2-10-2">
                  <title>Care partner covariates</title>
                  <p>The same demographics measured in patients will also be obtained from care partners. Care partner self-efficacy will be assessed via the Caregiver Inventory.<xref rid="R45" ref-type="bibr">45</xref> Preparedness of the care partner will be measured through the Caregiver Healthcare Task Difficulty and Preparedness Scales.<xref rid="R46" ref-type="bibr">46–48</xref> The nature and intensity of care provided will be assessed through information about the relationship of the care partner to the LTR, the number of hours of care provided per week, the care partner’s duration of caregiving responsibilities and travel time to the LTR’s residence. Healthcare navigation skills will be assessed using the LTKQ, and care partner burden will be measured using the Zarit Burden Inventory, short form (ZBI-12).<xref rid="R49" ref-type="bibr">49</xref></p>
                </sec>
              </sec>
              <sec id="s2-11">
                <title>Outcomes</title>
                <sec id="s2-11-1">
                  <title>Medication adherence</title>
                  <p>The primary adherence outcome will be measured using (1) 24-hour recall defined as patient self-report of how many pills and how often each medication was taken in the last 24 hours. Additional secondary adherence measures include (2) the ASK-12 scale that assesses general medication attitudes and beliefs,<xref rid="R50" ref-type="bibr">50</xref> (3) regimen knowledge<xref rid="R6" ref-type="bibr">6 51–55</xref> and (4) a biological measure using tacrolimus intrapatient variability. RCs will administer the 24-hour recall where correct dosing will be measured as yes/no for each drug for the following domains: dose (number of pills), spacing (hours between doses), frequency (times per day) and total pills per day. General medication adherence will then be assessed with the brief ASK-12 scale that has three adherence related-subscales: medication behaviour, health beliefs and inconvenience/forgetfulness.<xref rid="R50" ref-type="bibr">50</xref> As part of the regimen knowledge assessment, we will ask the patient about the medical indication for each medication. Subsequently, understanding of proper dosing will be assessed by asking the patient to self-report the number of pills and spacing (hours apart) for each medication taken in the last 24 hours. Patient IS variability will be assessed with the tacrolimus coefficient of variation (CoV) (100×SD/mean tacrolimus concentration), the medication level variability index (MLVI, SD of at least three values), and tacrolimus time in the therapeutic range (TTR).<xref rid="R56" ref-type="bibr">56–58</xref> Tacrolimus variability is associated with non-adherence (eg, wrong or skipped dose, wrong drug timing, wrong laboratory timing), medication toxicity, kidney injury and poorer survival.<xref rid="R56" ref-type="bibr">56 59 60</xref> Calculations will be made at baseline, 6, 12 and 18 months using ≥3 levels obtained over the previous 3–6 months based on availability.</p>
                </sec>
                <sec id="s2-11-2">
                  <title>Health related-quality of life</title>
                  <p>We will measure the health-related quality of life (HRQoL) of patients using the EQ-5D-5L. This survey assesses mobility, self-care, usual activities, pain/discomfort and anxiety/depression with five questions, each with five possible answers, and, separately, self-rated health on a vertical visual analogue scale.<xref rid="R61" ref-type="bibr">61 62</xref></p>
                </sec>
                <sec id="s2-11-3">
                  <title>Functional health status</title>
                  <p>The functional health status of patients will be assessed at study visits using components of the Liver Frailty Index (LFI) as well as the timed and go test. Objective measures of physical function will be assessed with the sit-to-stand, balance and grip strength tests. Using these measures, we will calculate physical frailty with the validated LFI that combines grip strength, balance and timed chair stand measures to classify patients’ frailty severity.<xref rid="R63" ref-type="bibr">63</xref></p>
                </sec>
                <sec id="s2-11-4">
                  <title>Clinical outcomes</title>
                  <p>We will assess (1) days hospitalised, (2) days alive and out of hospital (DAOH), (3) liver graft outcomes: liver graft rejection and liver graft failure, (4) mortality. Days hospitalised and DAOH are both patient-centred, clinical outcomes validated for clinical trials.<xref rid="R39" ref-type="bibr">39 64 65</xref> Liver graft rejection, liver graft failure and mortality will be assessed by liver biopsy and EHR, obtained as per usual care. Post-transplant infections will be assessed from the EHR using previous methodology developed by our group.<xref rid="R6" ref-type="bibr">6</xref></p>
                </sec>
                <sec id="s2-11-5">
                  <title>Chronic disease control</title>
                  <p>These data will be obtained at the end of the study from the EHR for the entire study period. We will examine longitudinal measures of chronic disease management including (1) office or hospital-based systolic/diastolic blood pressure, (2) haemoglobin A1c (HbA1c), (3) lipid profile (low-density lipoprotein cholesterol (LDL), triglycerides (TG)) and (4) kidney function measured by estimated rate (estimated glomerular filtration rate (eGFR); mL/min/1.73m<sup>2</sup>).</p>
                </sec>
                <sec id="s2-11-6">
                  <title>Acceptability, feasibility</title>
                  <p>To evaluate the acceptability and feasibility of the TEST trial, we will (1) conduct staff interviews, (2) obtain field notes from clinicians and research staff and (3) conduct patient, caregiver, transplant clinician exit surveys to assess satisfaction with the intervention.<xref rid="R20" ref-type="bibr">20 51</xref></p>
                </sec>
                <sec id="s2-11-7">
                  <title>Fidelity</title>
                  <p>Fidelity will be measured through (1) completion of monthly assessments, (2) patient/care partner engagement with text messages, (3) per cent of care alerts with clinical actions taken. Engagement with text messages will be analysed by assessing the per cent that result in appropriate EHR documentation and transplant centre responses. Finally, transplant centre responses along with percent of laboratory, appointments and self-management reminders appropriately deployed will be analysed.</p>
                </sec>
                <sec id="s2-11-8">
                  <title>Costs</title>
                  <p>The cost of the TEST strategy will be conducted at UPenn LT and will be analysed by investigating (1) W2H portal and implementation costs, (2) care partner, research staff and clinical staff time and (3) differences in LTRs’ healthcare use during the trial. Measured costs will reflect the perspective of a transplant centre considering adoption of the intervention, omitting costs related to research. Implementation costs include: evaluating the suitability of LTRs for the intervention; the technology platform and features needed for TEST, including the automatic text reminders for medications, labs and visits; the monthly adherence assessment to be completed by LTRs and caregivers, and staff time. We will design the staff time measurement strategy in consultation with the transplant coordinators and will use time diaries, interviews and direct observation if necessary. Because caregiving is essential to good LTR outcomes, and can impose substantial costs on caregivers, we will survey caregivers to measure their time spent and other burdens and expenditures. We will develop the survey based on items from the National Health and Aging Trends Study’s National Study of Caregiving,<xref rid="R66" ref-type="bibr">66</xref> to ask about the medical care and other tasks involved in caregiving, such as cleaning, shopping and paying bills; any out-of-pocket expenditures, and the pressures on the rest of the caregiver’s life. Finally, we will use the EHR to measure patients’ medical care use in each study arm.</p>
                </sec>
              </sec>
              <sec id="s2-12">
                <title>Data analysis plan</title>
                <p>Better adherence to IS and non-IS regimens, greater treatment knowledge and fewer dosing errors are the primary outcomes of interest for aim 1. For each subject, we will have adherence measures at months 6, 12 and 18, representing adherence during follow-up intervals (0, 3], (3, 6], (6, 12] and (12, 18], respectively. Adherence will be measured four different ways: (1) 24-hour recall, (2) ASK-12, (3) regimen knowledge and (4) tacrolimus variability. The ASK-12 questionnaire will be used to quantify barriers to adherence, with measurements at months 0, 6, 12 and 18. For each patient, the tacrolimus variability outcome will be represented by four time-interval specific Tac-CoV values modelled through a linear mixed model, including patient-specific random intercepts. For this outcome, the TEST and usual care groups will be compared through a linear mixed model with random patient-specific intercepts. Regimen knowledge will be modelled as a continuous outcome using the same approach. We will also carry out sensitivity analyses to further evaluate models: (1) we will repeat the analysis using different percentage thresholds to define pill count adherence (eg, 90%) and will also evaluate adherence as a continuous measure. We will replace Tac-CoV with the MLVI (computed as tacrolimus SD) and will analyse the MLVI as a continuous and as a binary outcome (MLVI&gt;2). We will analyse tacrolimus TTR as an additional outcome.</p>
                <p>Secondary outcomes of interest for aim 1 include: (1) better health status and fewer hospitalisation days as well as (2) more optimal chronic disease control. Better health status and fewer hospitalisation days will be measured through (i) days hospitalised, (ii) HRQoL, (iii) graft failure, (iv) graft rejection and (v) infections. Days hospitalised will be modelled using a proportional rates model, which is essentially the recurrent event version of Cox regression. EQ-5D-5L scores (available at months 0–3, 6, 12 and 18) will be modelled using a linear mixed model. Cox regression will be used to model graft failure. For graft rejection and infections, we will use the proportional rates model described above as both events may occur multiple times per patient. Linear mixed models will be fitted to the outcomes of blood pressure, HbA1c, eGFR, lipid levels.</p>
                <p><xref rid="F3" ref-type="fig">Figure 3</xref> shows power for each of the main analyses proposed in aim 1. With a sample size of n=360, we have planned for a study dropout rate of 10% giving n=320. If drop-out exceeds 10%, we will use inverse probability of censoring weighting, such that the weighted complete data represent the study sample.<xref rid="R67" ref-type="bibr">67</xref> Multiple imputation,<xref rid="R68" ref-type="bibr">68</xref> with 10 imputed data sets, will be used to impute missing values for covariates and outcomes with missingness &gt;10% with PROC MI and PROC MIANALYZE (SAS, V.9.4).</p>
                <fig position="float" id="F3">
                  <label>Figure 3</label>
                  <caption>
                    <p>Power analyses.</p>
                  </caption>
                  <graphic xlink:href="bmjopen-2023-075172f03" position="float"/>
                </fig>
                <p>For aim 2, we will determine the fidelity of each component of the intervention over time and investigate patient, care partner, provider or transplant centre factors associated with optimal implementation. Mixed methods will be employed using a convergent parallel design to obtain data on intervention implementation. We will capture four data sources: (1) W2H research dashboard, (2) EHR, (3) field notes and (4) clinic staff. We will examine if receipt of W2H tools increased LTR adherence and impacted clinical outcomes. At 12-month and 18-month interviews, a random sample of 25 patients and 25 care partners from the intervention arm at each site will be asked additional, semi-structured questions to explore (1) personal challenges with regimen adherence, (2) perceived value of the W2H portal tools, (3) unmet needs and acceptability of other tools and approaches to support medication use. Interviews will be audio-recorded and transcribed. Group or one-on-one interviews will be held with transplant staff to assess the intervention’s impact on workflow.</p>
                <p>Quantitative and qualitative findings pertaining to aim 2 will be merged to answer (1) whether the intervention was implemented as planned (eg, fidelity) and (2) whether, from a user perspective, the interventions require modification and how. In this approach, both analyses are conducted separately and merged for side-by-side data comparisons. For qualitative data, we will review and explore any transcribed patient interviews and clinic staff discussions using content and ethnographic analysis. The effect of patient characteristics on fidelity will be quantified using mixed logistic regression; we will fit separate models for patients and care partners. With respect to providers, fidelity will be represented by the fractions of alerts that trigger a clinical response. Response probability will be modelled through mixed logistic regression where, for each provider, the number of ‘trials’ and ‘successes’ will be set to the number of alerts and responses thereto, respectively. We will assess the relationship between the intervention effect (ie, intervention vs usual care) and fidelity through interaction terms. For each time point (eg, 12 months), we will have a covariate for survey completion fraction during the preceding follow-up interval (eg, 5/6 surveys completed for months 7–12).</p>
                <p>For aim 3, we will assess the costs and cost-effectiveness of the TEST intervention from a transplant centre perspective. We will evaluate the cost-effectiveness of the TEST intervention, relating implementation costs to any changes in HRQoL, as measured by the EQ-5D-5L. We will also relate implementation costs to medication adherence and days hospitalised, the primary and secondary trial outcomes. The costing and cost-effectiveness analyses will be summarised in the form of centre costs per LTR (with detail by type of cost) and in incremental cost-effectiveness ratios that show the difference in implementation costs between intervention and control arms divided by the difference in health outcome (eg, EQ-5D-5L). One-way and multi-way sensitivity analyses will be conducted to determine the key drivers behind costs and cost-effectiveness ratios, with particular attention to factors such as attrition, that may differ between the trial and ordinary practice.</p>
              </sec>
              <sec id="s2-13">
                <title>Data</title>
                <p>The study contains potentially sensitive transplant outcomes data that will be made available on request.</p>
              </sec>
            </sec>
            <sec id="s3">
              <title>Ethics and dissemination</title>
              <p>The University of Pennsylvania Review Board has approved the study as the sIRB of record (protocol # 849575). All protocol changes will be communicated and approved by the sIRB. An external Data Safety and Monitoring Board (DSMB) will serve as a safety monitoring entity for this study. The DSMB will include a biostatistician, and three researchers with relevant expertise. This is a minimal risk study with no interim analyses or stopping rules. Any study related serious adverse events will be reported to the site PI and study PI within 3 days and to the DSMB, IRB, sponsor (NIDDK) in writing within 7 days of investigators becoming aware. To ensure data confidentiality records will be stored in a secured REDCap database environment. Our informed consent document for this clinical trial will include a statement acknowledging the posting of eligibility criteria and study information on <ext-link xlink:href="http://clinicaltrials.gov/" ext-link-type="uri">clinicaltrials.gov</ext-link>, as well as the subsequent results.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="d64e271">
                <caption>
                  <title>Reviewer comments</title>
                </caption>
                <media xlink:href="bmjopen-2023-075172.reviewer_comments.pdf"/>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="d64e272">
                <caption>
                  <title>Author's
manuscript</title>
                </caption>
                <media xlink:href="bmjopen-2023-075172.draft_revisions.pdf"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="other">
                <p><bold>Twitter:</bold> @serperm, @DanielaLadnerMD</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Contributors:</bold> MS: study conception and design, drafting of manuscript, critically revising manuscript for important intellectual content. ABu: drafting of manuscript, critically revising manuscript for important intellectual content. DES: study conception and design, data analysis, drafting of manuscript, critically revising manuscript for important intellectual content. RM: data acquisition, drafting of manuscript, critically revising manuscript for important intellectual content. ABa: critically revising manuscript for important intellectual content. DSG: critically revising manuscript for important intellectual content. EFM: critically revising manuscript for important intellectual content. SJM: study conception and design, critically revising manuscript for important intellectual content. LBR: study conception and design, critically revising manuscript for important intellectual content. ACC: critically revising manuscript for important intellectual content. DPL: critically revising manuscript for important intellectual content, JYB: critically revising manuscript for important intellectual content. MSW -study conception and design, critically revising manuscript for important intellectual content. All authors have approved the final manuscript.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Funding:</bold> This study is supported by the National Institutes of Health (NIH), National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), R01DK131547, PI: MS.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Competing interests:</bold> MS reports additional grants from NIH/NIDDK/NIAAA, PCORI, and Grifols, SA.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Patient and public involvement:</bold> Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Provenance and peer review:</bold> Not commissioned; peer reviewed for ethical and funding approval prior to submission.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Supplemental material:</bold> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p>
              </fn>
            </fn-group>
            <sec sec-type="ethics-statement">
              <title>Ethics statements</title>
              <sec>
                <title>Patient consent for publication</title>
                <p content-type="ethics-consent-to-publish">Not applicable.</p>
              </sec>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Orman</surname><given-names>ES</given-names></string-name>, <string-name><surname>Roberts</surname><given-names>A</given-names></string-name>, <string-name><surname>Ghabril</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Trends in characteristics, mortality, and other outcomes of patients with newly diagnosed cirrhosis</article-title>. <source>JAMA Netw Open</source><year>2019</year>;<volume>2</volume>:<elocation-id>e196412</elocation-id>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.6412</pub-id><pub-id pub-id-type="pmid">31251379</pub-id></mixed-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tapper</surname><given-names>EB</given-names></string-name>, <string-name><surname>Parikh</surname><given-names>ND</given-names></string-name></person-group>. <article-title>Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study</article-title>. <source>BMJ</source><year>2018</year>;<volume>362</volume>:<elocation-id>k2817</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmj.k2817</pub-id><pub-id pub-id-type="pmid">30021785</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>WR</given-names></string-name>, <string-name><surname>Lake</surname><given-names>JR</given-names></string-name>, <string-name><surname>Smith</surname><given-names>JM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>OPTN/SRTR 2017 annual data report: liver</article-title>. <source>Am J Transplant</source><year>2019</year>;<volume>19 Suppl 2</volume>:<fpage>184</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.15276</pub-id><pub-id pub-id-type="pmid">30811890</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Habka</surname><given-names>D</given-names></string-name>, <string-name><surname>Mann</surname><given-names>D</given-names></string-name>, <string-name><surname>Landes</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Future economics of liver transplantation: a 20-year cost modeling forecast and the prospect of Bioengineering Autologous liver grafts</article-title>. <source>PLoS One</source><year>2015</year>;<volume>10</volume>:<elocation-id>e0131764</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0131764</pub-id><pub-id pub-id-type="pmid">26177505</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kwong</surname><given-names>A</given-names></string-name>, <string-name><surname>Kim</surname><given-names>WR</given-names></string-name>, <string-name><surname>Lake</surname><given-names>JR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>OPTN/SRTR 2018 annual data report: liver</article-title>. <source>Am J Transplant</source><year>2020</year>;<volume>20 Suppl s1</volume>:<fpage>193</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.15674</pub-id><pub-id pub-id-type="pmid">31898413</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Serper</surname><given-names>M</given-names></string-name>, <string-name><surname>Patzer</surname><given-names>RE</given-names></string-name>, <string-name><surname>Reese</surname><given-names>PP</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients</article-title>. <source>Liver Transpl</source><year>2015</year>;<volume>21</volume>:<fpage>22</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/lt.24023</pub-id><pub-id pub-id-type="pmid">25312406</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kamila</surname><given-names>P</given-names></string-name>, <string-name><surname>Smith</surname><given-names>SG</given-names></string-name>, <string-name><surname>Patzer</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Medication regimen complexity in kidney and liver transplant recipients</article-title>. <source>Transplantation</source><year>2014</year>;<volume>98</volume>:<fpage>e73</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000000403</pub-id><pub-id pub-id-type="pmid">25285955</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bittermann</surname><given-names>T</given-names></string-name>, <string-name><surname>Dwinnells</surname><given-names>K</given-names></string-name>, <string-name><surname>Chadha</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Low health literacy is associated with frailty and reduced likelihood of liver transplant listing: a prospective cohort study</article-title>. <source>Liver Transpl</source><year>2020</year>;<volume>26</volume>:<fpage>1409</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/lt.25830</pub-id><pub-id pub-id-type="pmid">32567232</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Serper</surname><given-names>M</given-names></string-name>, <string-name><surname>Reese</surname><given-names>PP</given-names></string-name>, <string-name><surname>Patzer</surname><given-names>RR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The prevalence, risk factors, and outcomes of medication trade-offs in kidney and liver transplant recipients: a pilot study</article-title>. <source>Transpl Int</source><year>2018</year>;<volume>31</volume>:<fpage>870</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/tri.13098</pub-id><pub-id pub-id-type="pmid">29178601</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jones</surname><given-names>LS</given-names></string-name>, <string-name><surname>Serper</surname><given-names>M</given-names></string-name></person-group>. <article-title>Medication non-adherence among liver transplant recipients</article-title>. <source>Curr Hepatology Rep</source><year>2020</year>;<volume>19</volume>:<fpage>327</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/s11901-020-00545-7</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dharancy</surname><given-names>S</given-names></string-name>, <string-name><surname>Giral</surname><given-names>M</given-names></string-name>, <string-name><surname>Tetaz</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT</article-title>. <source>Clin Transplant</source><year>2012</year>;<volume>26</volume>:<fpage>E293</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0012.2012.01652.x</pub-id><pub-id pub-id-type="pmid">22686953</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lieber</surname><given-names>SR</given-names></string-name>, <string-name><surname>Volk</surname><given-names>ML</given-names></string-name></person-group>. <article-title>Non-adherence and graft failure in adult liver transplant recipients</article-title>. <source>Dig Dis Sci</source><year>2013</year>;<volume>58</volume>:<fpage>824</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1007/s10620-012-2412-0</pub-id><pub-id pub-id-type="pmid">23053889</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fine</surname><given-names>RN</given-names></string-name>, <string-name><surname>Becker</surname><given-names>Y</given-names></string-name>, <string-name><surname>De Geest</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Nonadherence consensus conference summary report</article-title>. <source>Am J Transplant</source><year>2009</year>;<volume>9</volume>:<fpage>35</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2008.02495.x</pub-id><pub-id pub-id-type="pmid">19133930</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dew</surname><given-names>MA</given-names></string-name>, <string-name><surname>DiMartini</surname><given-names>AF</given-names></string-name>, <string-name><surname>De Vito Dabbs</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation</article-title>. <source>Transplantation</source><year>2007</year>;<volume>83</volume>:<fpage>858</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1097/01.tp.0000258599.65257.a6</pub-id><pub-id pub-id-type="pmid">17460556</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Bleser</surname><given-names>L</given-names></string-name>, <string-name><surname>Dobbels</surname><given-names>F</given-names></string-name>, <string-name><surname>Berben</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways</article-title>. <source>Transpl Int</source><year>2011</year>;<volume>24</volume>:<fpage>882</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-2277.2011.01296.x</pub-id><pub-id pub-id-type="pmid">21740471</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Geest</surname><given-names>S</given-names></string-name>, <string-name><surname>Burkhalter</surname><given-names>H</given-names></string-name>, <string-name><surname>Bogert</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss transplant cohort study</article-title>. <source>Transpl Int</source><year>2014</year>;<volume>27</volume>:<fpage>657</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1111/tri.12312</pub-id><pub-id pub-id-type="pmid">24628915</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Carroll</surname><given-names>RE</given-names></string-name>, <string-name><surname>McGregor</surname><given-names>LM</given-names></string-name>, <string-name><surname>Swanson</surname><given-names>V</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Adherence to medication after liver transplantation in Scotland: a pilot study</article-title>. <source>Liver Transpl</source><year>2006</year>;<volume>12</volume>:<fpage>1862</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/lt.20828</pub-id><pub-id pub-id-type="pmid">16773637</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burra</surname><given-names>P</given-names></string-name>, <string-name><surname>Germani</surname><given-names>G</given-names></string-name>, <string-name><surname>Gnoato</surname><given-names>F</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Adherence in liver transplant recipients</article-title>. <source>Liver Transpl</source><year>2011</year>;<volume>17</volume>:<fpage>760</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1002/lt.22294</pub-id><pub-id pub-id-type="pmid">21384527</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nair</surname><given-names>S</given-names></string-name>, <string-name><surname>Verma</surname><given-names>S</given-names></string-name>, <string-name><surname>Thuluvath</surname><given-names>PJ</given-names></string-name></person-group>. <article-title>Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States</article-title>. <source>Hepatology</source><year>2002</year>;<volume>35</volume>:<fpage>105</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1053/jhep.2002.30318</pub-id><pub-id pub-id-type="pmid">11786965</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Serper</surname><given-names>M</given-names></string-name>, <string-name><surname>Barankay</surname><given-names>I</given-names></string-name>, <string-name><surname>Chadha</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>A randomized, controlled, behavioral intervention to promote walking after abdominal organ transplantation: results from the LIFT study</article-title>. <source>Transpl Int</source><year>2020</year>;<volume>33</volume>:<fpage>632</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1111/tri.13570</pub-id><pub-id pub-id-type="pmid">31925833</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roccaro</surname><given-names>GA</given-names></string-name>, <string-name><surname>Mitrani</surname><given-names>R</given-names></string-name>, <string-name><surname>Hwang</surname><given-names>W-T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Sustained virological response is associated with a decreased risk of posttransplant diabetes mellitus in liver transplant recipients with hepatitis C-related liver disease</article-title>. <source>Liver Transpl</source><year>2018</year>;<volume>24</volume>:<fpage>1665</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1002/lt.25351</pub-id><pub-id pub-id-type="pmid">30291672</pub-id></mixed-citation>
              </ref>
              <ref id="R22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Watt</surname><given-names>KDS</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>RA</given-names></string-name>, <string-name><surname>Kremers</surname><given-names>WK</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Long-term probability of and mortality from de novo malignancy after liver transplantation</article-title>. <source>Gastroenterology</source><year>2009</year>;<volume>137</volume>:<fpage>2010</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2009.08.070</pub-id><pub-id pub-id-type="pmid">19766646</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lucey</surname><given-names>MR</given-names></string-name>, <string-name><surname>Terrault</surname><given-names>N</given-names></string-name>, <string-name><surname>Ojo</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Long-term management of the successful adult liver transplant: 2012 practice guideline by the American association for the study of liver diseases and the American society of transplantation</article-title>. <source>Liver Transpl</source><year>2013</year>;<volume>19</volume>:<fpage>3</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1002/lt.23566</pub-id><pub-id pub-id-type="pmid">23281277</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Neuberger</surname><given-names>JM</given-names></string-name>, <string-name><surname>Bechstein</surname><given-names>WO</given-names></string-name>, <string-name><surname>Kuypers</surname><given-names>DRJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on managing Modifiable risk in transplantation (COMMIT) group</article-title>. <source>Transplantation</source><year>2017</year>;<volume>101</volume>:<fpage>S1</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000001651</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klein</surname><given-names>A</given-names></string-name>, <string-name><surname>Otto</surname><given-names>G</given-names></string-name>, <string-name><surname>Krämer</surname><given-names>I</given-names></string-name></person-group>. <article-title>Impact of a pharmaceutical care program on liver transplant patients’ compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring</article-title>. <source>Transplantation</source><year>2009</year>;<volume>87</volume>:<fpage>839</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0b013e318199d122</pub-id><pub-id pub-id-type="pmid">19300186</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobbels</surname><given-names>F</given-names></string-name>, <string-name><surname>De Bleser</surname><given-names>L</given-names></string-name>, <string-name><surname>Berben</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-TX trial</article-title>. <source>J Heart Lung Transplant</source><year>2017</year>;<volume>36</volume>:<fpage>499</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1016/j.healun.2017.01.007</pub-id><pub-id pub-id-type="pmid">28162931</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harrison</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Badr</surname><given-names>S</given-names></string-name>, <string-name><surname>Hamandi</surname><given-names>B</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence</article-title>. <source>Transplantation</source><year>2017</year>;<volume>101</volume>:<fpage>1336</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000001279</pub-id><pub-id pub-id-type="pmid">27367473</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Webb</surname><given-names>JR</given-names></string-name>, <string-name><surname>Feinglass</surname><given-names>J</given-names></string-name>, <string-name><surname>Makoul</surname><given-names>G</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Can electronic health records help improve patients' understanding of medications?</article-title><source>Am J Manag Care</source><year>2010</year>;<volume>16</volume>:<fpage>919</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">21348562</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bailey</surname><given-names>SC</given-names></string-name>, <string-name><surname>Belter</surname><given-names>LT</given-names></string-name>, <string-name><surname>Pandit</surname><given-names>AU</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The availability, functionality, and quality of mobile applications supporting medication self-management</article-title>. <source>J Am Med Inform Assoc</source><year>2014</year>;<volume>21</volume>:<fpage>542</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/amiajnl-2013-002232</pub-id><pub-id pub-id-type="pmid">24163156</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Granger</surname><given-names>BB</given-names></string-name>, <string-name><surname>Bosworth</surname><given-names>HB</given-names></string-name></person-group>. <article-title>Medication adherence: emerging use of technology</article-title>. <source>Curr Opin Cardiol</source><year>2011</year>;<volume>26</volume>:<fpage>279</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1097/HCO.0b013e328347c150</pub-id><pub-id pub-id-type="pmid">21597368</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hou</surname><given-names>MY</given-names></string-name>, <string-name><surname>Hurwitz</surname><given-names>S</given-names></string-name>, <string-name><surname>Kavanagh</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial</article-title>. <source>Obstet Gynecol</source><year>2010</year>;<volume>116</volume>:<fpage>633</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1097/AOG.0b013e3181eb6b0f</pub-id><pub-id pub-id-type="pmid">20733446</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hardy</surname><given-names>H</given-names></string-name>, <string-name><surname>Kumar</surname><given-names>V</given-names></string-name>, <string-name><surname>Doros</surname><given-names>G</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy</article-title>. <source>AIDS Patient Care STDS</source><year>2011</year>;<volume>25</volume>:<fpage>153</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1089/apc.2010.0006</pub-id><pub-id pub-id-type="pmid">21323532</pub-id></mixed-citation>
              </ref>
              <ref id="R33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ammenwerth</surname><given-names>E</given-names></string-name>, <string-name><surname>Schnell-Inderst</surname><given-names>P</given-names></string-name>, <string-name><surname>Hoerbst</surname><given-names>A</given-names></string-name></person-group>. <article-title>The impact of electronic patient portals on patient care: a systematic review of controlled trials</article-title>. <source>J Med Internet Res</source><year>2012</year>;<volume>14</volume>:<elocation-id>e162</elocation-id>. <pub-id pub-id-type="doi">10.2196/jmir.2238</pub-id><pub-id pub-id-type="pmid">23183044</pub-id></mixed-citation>
              </ref>
              <ref id="R34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldzweig</surname><given-names>CL</given-names></string-name>, <string-name><surname>Orshansky</surname><given-names>G</given-names></string-name>, <string-name><surname>Paige</surname><given-names>NM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Electronic patient portals: evidence on health outcomes, satisfaction, efficiency, and attitudes</article-title>. <source>Ann Intern Med</source><year>2013</year>;<volume>159</volume>:<fpage>677</fpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-159-10-201311190-00006</pub-id><pub-id pub-id-type="pmid">24247673</pub-id></mixed-citation>
              </ref>
              <ref id="R35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taha</surname><given-names>J</given-names></string-name>, <string-name><surname>Czaja</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Sharit</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Factors affecting usage of a personal health record (PHR) to manage health</article-title>. <source>Psychol Aging</source><year>2013</year>;<volume>28</volume>:<fpage>1124</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1037/a0033911</pub-id><pub-id pub-id-type="pmid">24364414</pub-id></mixed-citation>
              </ref>
              <ref id="R36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andel</surname><given-names>R</given-names></string-name>, <string-name><surname>Crowe</surname><given-names>M</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>NL</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Complexity of work and risk of Alzheimer's disease: a population-based study of Swedish twins</article-title>. <source>J Gerontol B Psychol Sci Soc Sci</source><year>2005</year>;<volume>60</volume>:<fpage>251</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/geronb/60.5.p251</pub-id></mixed-citation>
              </ref>
              <ref id="R37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Finkel</surname><given-names>D</given-names></string-name>, <string-name><surname>Andel</surname><given-names>R</given-names></string-name>, <string-name><surname>Gatz</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The role of occupational complexity in trajectories of cognitive aging before and after retirement</article-title>. <source>Psychol Aging</source><year>2009</year>;<volume>24</volume>:<fpage>563</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1037/a0015511</pub-id><pub-id pub-id-type="pmid">19739912</pub-id></mixed-citation>
              </ref>
              <ref id="R38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>WR</given-names></string-name>, <string-name><surname>Biggins</surname><given-names>SW</given-names></string-name>, <string-name><surname>Kremers</surname><given-names>WK</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Hyponatremia and mortality among patients on the liver-transplant waiting list</article-title>. <source>N Engl J Med</source><year>2008</year>;<volume>359</volume>:<fpage>1018</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0801209</pub-id><pub-id pub-id-type="pmid">18768945</pub-id></mixed-citation>
              </ref>
              <ref id="R39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bittermann</surname><given-names>T</given-names></string-name>, <string-name><surname>Hubbard</surname><given-names>RA</given-names></string-name>, <string-name><surname>Serper</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Healthcare utilization after liver transplantation is highly variable among both centers and recipients</article-title>. <source>Am J Transplant</source><year>2018</year>;<volume>18</volume>:<fpage>1197</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.14539</pub-id><pub-id pub-id-type="pmid">29024364</pub-id></mixed-citation>
              </ref>
              <ref id="R40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Serper</surname><given-names>M</given-names></string-name>, <string-name><surname>Bittermann</surname><given-names>T</given-names></string-name>, <string-name><surname>Rossi</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Functional status, healthcare utilization, and the costs of liver transplantation</article-title>. <source>Am J Transplant</source><year>2018</year>;<volume>18</volume>:<fpage>1187</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.14576</pub-id><pub-id pub-id-type="pmid">29116679</pub-id></mixed-citation>
              </ref>
              <ref id="R41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nasreddine</surname><given-names>ZS</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>NA</given-names></string-name>, <string-name><surname>Bédirian</surname><given-names>V</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment</article-title>. <source>J Am Geriatr Soc</source><year>2005</year>;<volume>53</volume>:<fpage>695</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1532-5415.2005.53221.x</pub-id><pub-id pub-id-type="pmid">15817019</pub-id></mixed-citation>
              </ref>
              <ref id="R42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agarwal</surname><given-names>A</given-names></string-name>, <string-name><surname>Taneja</surname><given-names>S</given-names></string-name>, <string-name><surname>Chopra</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Animal naming test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy</article-title>. <source>Clin Exp Hepatol</source><year>2020</year>;<volume>6</volume>:<fpage>116</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.5114/ceh.2019.95105</pub-id><pub-id pub-id-type="pmid">32728628</pub-id></mixed-citation>
              </ref>
              <ref id="R43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Conor</surname><given-names>R</given-names></string-name>, <string-name><surname>Hebert-Beirne</surname><given-names>J</given-names></string-name>, <string-name><surname>Kwasny</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Structural and functional support among US older adults with asthma: cross-sectional associations with medication adherence</article-title>. <source>BMJ Open</source><year>2019</year>;<volume>9</volume>:<elocation-id>e027430</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2018-027430</pub-id></mixed-citation>
              </ref>
              <ref id="R44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weiss</surname><given-names>BD</given-names></string-name>, <string-name><surname>Mays</surname><given-names>MZ</given-names></string-name>, <string-name><surname>Martz</surname><given-names>W</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Quick assessment of literacy in primary care: the newest vital sign</article-title>. <source>Ann Fam Med</source><year>2005</year>;<volume>3</volume>:<fpage>514</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1370/afm.405</pub-id><pub-id pub-id-type="pmid">16338915</pub-id></mixed-citation>
              </ref>
              <ref id="R45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Merluzzi</surname><given-names>TV</given-names></string-name>, <string-name><surname>Philip</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Vachon</surname><given-names>DO</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Assessment of self-efficacy for caregiving: the critical role of self-care in caregiver stress and burden</article-title>. <source>Palliat Support Care</source><year>2011</year>;<volume>9</volume>:<fpage>15</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1017/S1478951510000507</pub-id><pub-id pub-id-type="pmid">21352614</pub-id></mixed-citation>
              </ref>
              <ref id="R46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boyd</surname><given-names>CM</given-names></string-name>, <string-name><surname>Wolff</surname><given-names>JL</given-names></string-name>, <string-name><surname>Giovannetti</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Healthcare task difficulty among older adults with multimorbidity</article-title>. <source>Med Care</source><year>2014</year>;<volume>52 Suppl 3</volume>:<fpage>S118</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1097/MLR.0b013e3182a977da</pub-id><pub-id pub-id-type="pmid">24561750</pub-id></mixed-citation>
              </ref>
              <ref id="R47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giovannetti</surname><given-names>ER</given-names></string-name>, <string-name><surname>Wolff</surname><given-names>JL</given-names></string-name>, <string-name><surname>Xue</surname><given-names>Q-L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Difficulty assisting with health care tasks among caregivers of multimorbid older adults</article-title>. <source>J Gen Intern Med</source><year>2012</year>;<volume>27</volume>:<fpage>37</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1007/s11606-011-1831-5</pub-id><pub-id pub-id-type="pmid">21874385</pub-id></mixed-citation>
              </ref>
              <ref id="R48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Archbold</surname><given-names>PG</given-names></string-name>, <string-name><surname>Stewart</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Greenlick</surname><given-names>MR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Mutuality and preparedness as predictors of caregiver role strain</article-title>. <source>Res Nurs Health</source><year>1990</year>;<volume>13</volume>:<fpage>375</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1002/nur.4770130605</pub-id><pub-id pub-id-type="pmid">2270302</pub-id></mixed-citation>
              </ref>
              <ref id="R49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gratão</surname><given-names>ACM</given-names></string-name>, <string-name><surname>Brigola</surname><given-names>AG</given-names></string-name>, <string-name><surname>Ottaviani</surname><given-names>AC</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Brief version of Zarit burden interview (ZBI) for burden assessment in older caregivers</article-title>. <source>Dement Neuropsychol</source><year>2019</year>;<volume>13</volume>:<fpage>122</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1590/1980-57642018dn13-010015</pub-id><pub-id pub-id-type="pmid">31073389</pub-id></mixed-citation>
              </ref>
              <ref id="R50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matza</surname><given-names>LS</given-names></string-name>, <string-name><surname>Park</surname><given-names>J</given-names></string-name>, <string-name><surname>Coyne</surname><given-names>KS</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Derivation and validation of the ASK-12 adherence barrier survey</article-title>. <source>Ann Pharmacother</source><year>2009</year>;<volume>43</volume>:<fpage>1621</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1345/aph.1M174</pub-id><pub-id pub-id-type="pmid">19776298</pub-id></mixed-citation>
              </ref>
              <ref id="R51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Serper</surname><given-names>M</given-names></string-name>, <string-name><surname>Ladner</surname><given-names>DP</given-names></string-name>, <string-name><surname>Curtis</surname><given-names>LM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Transplant regimen adherence for kidney recipients by engaging information technologies (TAKE IT): rationale and methods for a randomized controlled trial of a strategy to promote medication adherence among transplant recipients</article-title>. <source>Contemp Clin Trials</source><year>2021</year>;<volume>103</volume>:<fpage>106294</fpage>. <pub-id pub-id-type="doi">10.1016/j.cct.2021.106294</pub-id><pub-id pub-id-type="pmid">33515781</pub-id></mixed-citation>
              </ref>
              <ref id="R52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Patzer</surname><given-names>RE</given-names></string-name>, <string-name><surname>Serper</surname><given-names>M</given-names></string-name>, <string-name><surname>Reese</surname><given-names>PP</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Medication understanding, non-adherence, and clinical outcomes among adult kidney transplant recipients</article-title>. <source>Clin Transplant</source><year>2016</year>;<volume>30</volume>:<fpage>1294</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1111/ctr.12821</pub-id><pub-id pub-id-type="pmid">27447351</pub-id></mixed-citation>
              </ref>
              <ref id="R53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolf</surname><given-names>MS</given-names></string-name>, <string-name><surname>Curtis</surname><given-names>LM</given-names></string-name>, <string-name><surname>Waite</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Helping patients simplify and safely use complex prescription regimens</article-title>. <source>Arch Intern Med</source><year>2011</year>;<volume>171</volume>:<fpage>300</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1001/archinternmed.2011.39</pub-id><pub-id pub-id-type="pmid">21357804</pub-id></mixed-citation>
              </ref>
              <ref id="R54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolf</surname><given-names>MS</given-names></string-name>, <string-name><surname>Davis</surname><given-names>TC</given-names></string-name>, <string-name><surname>Arozullah</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Relation between literacy and HIV treatment knowledge among patients on HAART regimens</article-title>. <source>AIDS Care</source><year>2005</year>;<volume>17</volume>:<fpage>863</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1080/09540120500038660</pub-id><pub-id pub-id-type="pmid">16120503</pub-id></mixed-citation>
              </ref>
              <ref id="R55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolf</surname><given-names>MS</given-names></string-name>, <string-name><surname>Davis</surname><given-names>TC</given-names></string-name>, <string-name><surname>Cross</surname><given-names>JT</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Health literacy and patient knowledge in a Southern US HIV clinic</article-title>. <source>Int J STD AIDS</source><year>2004</year>;<volume>15</volume>:<fpage>747</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1258/0956462042395131</pub-id><pub-id pub-id-type="pmid">15537462</pub-id></mixed-citation>
              </ref>
              <ref id="R56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leino</surname><given-names>AD</given-names></string-name>, <string-name><surname>King</surname><given-names>EC</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>W</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: establishing baseline values</article-title>. <source>Am J Transplant</source><year>2019</year>;<volume>19</volume>:<fpage>1410</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.15199</pub-id><pub-id pub-id-type="pmid">30506623</pub-id></mixed-citation>
              </ref>
              <ref id="R57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Christina</surname><given-names>S</given-names></string-name>, <string-name><surname>Annunziato</surname><given-names>RA</given-names></string-name>, <string-name><surname>Schiano</surname><given-names>TD</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients</article-title>. <source>Liver Transpl</source><year>2014</year>;<volume>20</volume>:<fpage>1168</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1002/lt.23930</pub-id><pub-id pub-id-type="pmid">24931127</pub-id></mixed-citation>
              </ref>
              <ref id="R58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pierce</surname><given-names>DR</given-names></string-name>, <string-name><surname>West-Thielke</surname><given-names>P</given-names></string-name>, <string-name><surname>Hajjiri</surname><given-names>Z</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Clinical implications of tacrolimus time in therapeutic range and intrapatient variability in urban renal transplant recipients undergoing early corticosteroid withdrawal</article-title>. <source>Transplant Direct</source><year>2021</year>;<volume>7</volume>:<elocation-id>e698</elocation-id>. <pub-id pub-id-type="doi">10.1097/TXD.0000000000001155</pub-id><pub-id pub-id-type="pmid">34036168</pub-id></mixed-citation>
              </ref>
              <ref id="R59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Del Bello</surname><given-names>A</given-names></string-name>, <string-name><surname>Congy-Jolivet</surname><given-names>N</given-names></string-name>, <string-name><surname>Danjoux</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation</article-title>. <source>World J Gastroenterol</source><year>2018</year>;<volume>24</volume>:<fpage>1795</fpage>–<lpage>802</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v24.i16.1795</pub-id><pub-id pub-id-type="pmid">29713132</pub-id></mixed-citation>
              </ref>
              <ref id="R60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rayar</surname><given-names>M</given-names></string-name>, <string-name><surname>Tron</surname><given-names>C</given-names></string-name>, <string-name><surname>Jézéquel</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>High intrapatient variability of tacrolimus exposure in the early period after liver transplantation is associated with poorer outcomes</article-title>. <source>Transplantation</source><year>2018</year>;<volume>102</volume>:<fpage>e108</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000002052</pub-id><pub-id pub-id-type="pmid">29315140</pub-id></mixed-citation>
              </ref>
              <ref id="R61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Janssen</surname><given-names>MF</given-names></string-name>, <string-name><surname>Pickard</surname><given-names>AS</given-names></string-name>, <string-name><surname>Golicki</surname><given-names>D</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study</article-title>. <source>Qual Life Res</source><year>2013</year>;<volume>22</volume>:<fpage>1717</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1007/s11136-012-0322-4</pub-id><pub-id pub-id-type="pmid">23184421</pub-id></mixed-citation>
              </ref>
              <ref id="R62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herdman</surname><given-names>M</given-names></string-name>, <string-name><surname>Gudex</surname><given-names>C</given-names></string-name>, <string-name><surname>Lloyd</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)</article-title>. <source>Qual Life Res</source><year>2011</year>;<volume>20</volume>:<fpage>1727</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/s11136-011-9903-x</pub-id><pub-id pub-id-type="pmid">21479777</pub-id></mixed-citation>
              </ref>
              <ref id="R63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lai</surname><given-names>JC</given-names></string-name>, <string-name><surname>Segev</surname><given-names>DL</given-names></string-name>, <string-name><surname>McCulloch</surname><given-names>CE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Physical frailty after liver transplantation</article-title>. <source>Am J Transplant</source><year>2018</year>;<volume>18</volume>:<fpage>1986</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.14675</pub-id><pub-id pub-id-type="pmid">29380529</pub-id></mixed-citation>
              </ref>
              <ref id="R64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Setiawan</surname><given-names>VW</given-names></string-name>, <string-name><surname>Stram</surname><given-names>DO</given-names></string-name>, <string-name><surname>Porcel</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prevalence of chronic liver disease and cirrhosis by underlying cause in Understudied ethnic groups: the multiethnic cohort</article-title>. <source>Hepatology</source><year>2016</year>;<volume>64</volume>:<fpage>1969</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1002/hep.28677</pub-id><pub-id pub-id-type="pmid">27301913</pub-id></mixed-citation>
              </ref>
              <ref id="R65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fanaroff</surname><given-names>AC</given-names></string-name>, <string-name><surname>Cyr</surname><given-names>D</given-names></string-name>, <string-name><surname>Neely</surname><given-names>ML</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Days alive and out of hospital: exploring a patient-centered, pragmatic outcome in a clinical trial of patients with acute coronary syndromes</article-title>. <source>Circ Cardiovasc Qual Outcomes</source><year>2018</year>;<volume>11</volume>:<elocation-id>e004755</elocation-id>. <pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.118.004755</pub-id><pub-id pub-id-type="pmid">30562068</pub-id></mixed-citation>
              </ref>
              <ref id="R66">
                <label>66</label>
                <mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>NHATS</collab></person-group>. <article-title>National study of caregiving (NSOC)</article-title>. <comment>Available</comment>: <uri xlink:href="https://www.nhats.org/researcher/nsoc">https://www.nhats.org/researcher/nsoc</uri> [Accessed <comment>07 Mar 2023</comment>].</mixed-citation>
              </ref>
              <ref id="R67">
                <label>67</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Robins</surname><given-names>JM</given-names></string-name>, <string-name><surname>Finkelstein</surname><given-names>DM</given-names></string-name></person-group>. <article-title>Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests</article-title>. <source>Biometrics</source><year>2000</year>;<volume>56</volume>:<fpage>779</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1111/j.0006-341x.2000.00779.x</pub-id><pub-id pub-id-type="pmid">10985216</pub-id></mixed-citation>
              </ref>
              <ref id="R68">
                <label>68</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Little</surname><given-names>RJA</given-names></string-name>, <string-name><surname>Donald</surname><given-names>RB</given-names></string-name></person-group>. <source>Statistical analysis with missing data. 2nd Editio</source>. <publisher-loc>Hoboken</publisher-loc>: <publisher-name>John Wiley &amp; Sons, Ltd</publisher-name>, <year>2014</year>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
